NLRP3 and lung cancer: Our findings suggest that SE-EA extract and its active compounds, EGF-A and EGF-B, possess potential anti-cancer properties as they inhibit the invasion of A549 lung cancer cells stimulated by LPS and ATP via the NLRP3 inflammasome pathway.